0.03
-0.0114(-31.15%)
Currency In USD
Address
149 Fifth Avenue
New York City, NY 10010
United States of America
Phone
212 994 8200
Website
Sector
Healthcare
Industry
Biotechnology
Employees
1
First IPO Date
April 27, 2021
| Name | Title | Pay | Year Born |
| Dr. Alexander Kenneth Arrow C.F.A., M.D. | Chief Financial Officer & Secretary | 150,000 | 1971 |
| Dr. Garo H. Armen Ph.D. | Co-Founder & Executive Chairman of the Board | 0 | 1953 |
| Dr. Andrew Slee Ph.D. | Chief Operating Officer | 0 | 1950 |
| Dr. Robert Benjamin Stein M.D., Ph.D. | Chief Medical Officer & Director | 0 | 1951 |
Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.